Informed-money record
VRCA · Verrica Pharmaceuticals Inc.
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
6
Bearish filings
0
Named actors
5
Disclosed $ (bull / bear)
$18.0M / $0
Recent disclosures
6 of 6 in the window · linked to source| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2025-11-25 | Director Manning Paul B | bought | $11.7M | SEC ↗ |
| 2025-11-25 | Director Manning Paul B | bought | $5.8M | SEC ↗ |
| 2025-11-25 | Interim CFO Kirby John J. | bought | $15K | SEC ↗ |
| 2025-11-25 | CMO Rosenberg Noah L. | bought | $10K | SEC ↗ |
| 2025-11-25 | CEO and President Rieger Jayson | bought | $400K | SEC ↗ |
| 2025-11-25 | Chief Operating Officer Zawitz David | bought | $42K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Dispute or correct this record
Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals